Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Contrast shortage update: GE expects supply to 'progressively recover' soon

Production at the facility in Shanghai is expected to be near 100% starting on June 6.

Cardiac MRI findings can predict incident CVD years before onset

Prior imaging of the descending thoracic and abdominal aorta in study participants revealed thoracic aortic wall area (AWA), plaque prevalence and plaque volumes to be independently associated with incident CVD.

Example of various breast MRI protocol sequences that offer different types of soft tissue enhancement. Imaging performed on a Siemens Magnetom system. Breast MRI can help see through dense breast tissue to better detect cancers. #densebreasts #Breastdensity #BreastMRI

MRI-based radiomics boosts triple-negative breast cancer detection

"The present study validated the feasibility of using MRI-based radiomics to identify a disease prone to missed diagnosis and misdiagnosis," experts involved in the study said.

Thumbnail

One chemistry professor's role in increasing radioisotope production in the U.S.

The work of a chemistry professor at the University of Wisconsin-Milwaukee is helping to blaze the trail of reducing the United States’ dependence on foreign countries for vital medical isotopes. 

Photo and caption courtesy of American Journal of Roentgenology (AJR), American Roentgen Ray Society (ARRS). Used with permission.

Diffusion-weighted MRI boosts detection of locally recurrent pancreatic cancer

MRI with DWI images showed higher sensitivity in detecting local recurrence after PDAC resection.

Iodine contrast being loaded into a contrast injector in preparation for a cardiac CT scan at Duly Health and Care in Lisle, Illinois. The contrast shortage is causing some healthcare organizations to postpone exams and procedures and ration contrast supplies. Photo by Dave Fornell

ACR working with FDA and HHS to help address imaging contrast shortage

The American College of Radiology (ACR) announced this week its government relations staff has been engaging federal agencies in an effort to improve product availability and hasten resolution of the ongoing iodine contrast shortage.

Interview with Alan H. Matsumoto, MD, FSIR, FACR, FAHA, professor of radiology, chair of the Department of Radiology at the University of Virginia, vice chair of the American College of Radiology (ACR) Board of Chancellors, and the chairman of the ACR Commission on Interventional and Cardiovascular Radiology. He explains how the ACR and group purchasing organizations are asking the FDA to mitigate the contrast shortage with an emergency use authorization (EUA) to allow non-FDA cleared iodine contrast use.

VIDEO: American College of Radiology working with FDA to mitigate contrast shortage

Alan Matsumoto, MD, chair of the department of radiology at the University of Virginia and vice chair of the ACR Board of Chancellors, explains how the ACR and group purchasing organizations are asking the FDA to mitigate the contrast shortage with an emergency use authorization to allow non-FDA cleared iodine contrast agents to be imported.

Doctor patient with masks

New imaging technique detects post-COVID lung abnormalities

Conventional imaging did not detect the abnormalities, which MRI scans identified up to one year after infection.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.